• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Spark Therapeutics Appoints CTO

    Cryoport Launches ESG Program

    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail

    Thermo Fisher Scientific Completes Mesa Biotech Acquisition

    Ashfield Engage, Popit Form Digital Monitoring Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Solid Dose Market Trends

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    C2 Pharma Completes Multiple Regulatory Filings

    Bormioli Opens New Glass Research Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Syngene

    test company saurabh

    PCI Pharma Services

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Adare Pharma Solutions

    test company saurabh

    Alcami

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    India Report

    HPAPI Outsourcing Likely to Gain Traction

    A number of highly potent drugs will soon fall into the generic domain

    HPAPI Outsourcing Likely to Gain Traction
    Related CONTENT
    • Idifarma Strengthens Spray Drying Capabilities
    • Syngene
    • Piramal Pharma Solutions
    • Taros Chemicals
    • Sekisui
    S. Harachand, Contributing Editor09.11.18
    Faster growth of the therapeutic segments offering drugs to treat cancer and hormonal disorders are pushing up the demand for sourcing high potency APIs. Even though the majority of facilities producing cytotoxic compounds are located in North America and European countries, companies are turning their focus to developing nations for low-cost processes. Players from Asia-Pacific nations, including India, are expected to benefit as the proportion of firms outsourcing to locations with low-cost production technology increases. The region, noted for its booming HPAPI manufacturing, is a traditionally known hub for cost-competitive generic products.

    India, the generic powerhouse, stands alongside Japan and China as a favorable destination for HPAPI services in the Asia-Pacific region. HPAPI manufacturing in these parts is forecast to grow a little higher than the global average.

    The Asian region is expected to grow at the highest CAGR of 11.8% while the global HPAPIs market is poised to reach $26.84 billion by 2023 from $17.72 billion in 2018 growing at a CAGR of 8.7%, according to a recent report by Research and Markets. The growing market for contract manufacturers in this region, owing to low labor and manufacturing costs, helps the promotion of HPAPIs, among other things.

    Many innovators are on the lookout for facilities that have the capabilities and safety standards to handle HPAPIs for high growth segments such as oncology. CDMOs with integrated capabilities in HPAPIs will have a competitive edge over others as they can add value to companies outsourcing these products in terms of cost and timelines. Undoubtedly, end-to-end service providers that can take care of the entire product lifecycle from discovery to commercialization stand to gain.

    Piramal Pharma Solutions, for instance, started offering HPAPI services following its acquisition of Ash Stevens, the Riverview, MI-based contract manufacturer in August 2016. Currently, Piramal provides services ranging from conjugation development to clinical and commercial batch manufacturing and fill/finish to firms located in North America, Europe and Japan.

    Ash Stevens’ state-of-the-art manufacturing facility in Michigan has the containment controls for the safe handling and cGMP manufacture of small- and large-scale HPAPIs. Ash Stevens’ track record as a leader in HPAPIs with over five decades of experience in safe handling of potent compounds has proven to be a valuable addition to Piramal. Safety and containment requirements are very high to minimize the risk of handling HPAPIs. Piramal is, reportedly, planning to expand HPAPI capabilities at the Riverview facility.

    Piramal is also a noted player in antibody drug conjugates (ADCs) development. ADCs are highly potent biopharmaceutical drugs that link complex biological molecules like mAbs with cytotoxic drugs. ADCs have emerged as a promising class of anti-cancer therapeutics due to their high specificity in delivering cytotoxic/HPAPI drugs to target cells while significantly reducing the side-effects compared to chemotherapies. Steadily increasing demand for ADCs is also fueling the growth of HPAPIs.

    Dishman is another player that has expanded HPAPI capabilities through an outbound acquisition. The Ahmedabad-based CMO bought out Carbogen Amcis in 2007. The Swiss firm started a high containment factory at Bavla, in the western Indian state of Gujarat. With containment facilities spread across India, The Netherlands, Switzerland and China, Dishman Group is doing contract manufacturing and development of highly-potent compounds of all categories including cytostatics/cytotoxics.

    Several other players including Dr. Reddy’s, Neuland Labs, Arch Labs, and Syngene have capabilities to develop high potency compounds too.

    CMO investment in HPAPI facilities in India continues to be low despite the fact that the innovators prefer to outsource these potent agents from specialized manufacturers. The reason seems, primarily, because of the high level of safety standards and the requirement of specialized facilities. Apart from elaborate operating procedures, comprehensive quality management systems, and highly trained staff, it is also essential to have appropriate personnel protective equipment after evaluating occupational exposure to a compound and industrial hygiene programs for running HPAPI facilities.

    The absence of a global regulatory framework for handling HPAPIs is another challenge faced by the companies operating in this space.

    However, more CMOs are likely to be driven to HPAPIs in the days to come as a considerable number of highly potent drugs including the anti-cancer mAbs will soon fall into the generic domain, losing their patent protection.


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • facility
    • quality
    • cancer
    • production
    Suggested For You
    Idifarma Strengthens Spray Drying Capabilities Idifarma Strengthens Spray Drying Capabilities
    Syngene Syngene
    Piramal Pharma Solutions Piramal Pharma Solutions
    Taros Chemicals Taros Chemicals
    Sekisui Sekisui
    Vetio Animal Health Vetio Animal Health
    HPAPI Technology Evolution HPAPI Technology Evolution
    HPAPI Market Trends HPAPI Market Trends
    An “All-You-Can-Eat” Buffet for Excellence An “All-You-Can-Eat” Buffet for Excellence
    Are Indian Generic Firms Improving Compliance? Are Indian Generic Firms Improving Compliance?
    10	Lilly 10 Lilly
    Umicore API Facility Passes cGMP Audit Umicore API Facility Passes cGMP Audit
    Artelo, Syngene Enter Partnership Artelo, Syngene Enter Partnership
    ChargePoint Launches Smart Monitoring Technology ChargePoint Launches Smart Monitoring Technology
    2018 Annual Outsourcing Survey 2018 Annual Outsourcing Survey

    Related India Report

    • Injectables Firms Expand Capacity

      Injectables Firms Expand Capacity

      CDMOs see steriles demand grow.
      S. Harachand, Contributing Editor 11.17.20

    • Supply Chain Woes Vex Markets

      Supply Chain Woes Vex Markets

      Indian players ramp up chloroquine production
      S. Harachand, Contributing Editor 09.09.20

    • HCQ Comes Center Stage

      HCQ Comes Center Stage

      Indian players ramp up chloroquine production
      S. Harachand, Contributing Editor 05.05.20


    • Supply Chain
      Oral Solids Makers Face Corona Heat

      Oral Solids Makers Face Corona Heat

      CDMOs fear supply disruptions, price increases.
      S. Harachand, Contributing Editor 03.04.20

    • Biosimilars
      The Similar Mantra

      The Similar Mantra

      Early birds bet big on biosimilars.
      S. Harachand, Contributing Editor 01.28.20

    • APIs
      India to Track API Packs

      India to Track API Packs

      India is mulling a shakeup in the regulations governing the distribution of pharmaceutical products.
      S. Harachand, Contributing Editor 11.20.19


    • R&D
      Indian Firms Ramp Up R&D

      Indian Firms Ramp Up R&D

      Accelerating on research spend.
      S. Harachand, Contributing Editor 10.15.19

    • Cytotoxics and High Potency Manufacturing
      Highly Potent Expansions

      Highly Potent Expansions

      CDMOs see HPAPI demand rising
      S. Harachand, Contributing Editor 09.16.19

    • The Orphan Promise

      The Orphan Promise

      New policy on rare disease treatments likely soon
      S. Harachand, Contributing Editor 06.13.19


    • Biologics, Proteins, Vaccines
      Ebullient Bio CMOs

      Ebullient Bio CMOs

      Firms see rich dividends from biosimilars
      S. Harachand, Contributing Editor 05.07.19

    • R&D
      Strategic Discovery

      Strategic Discovery

      CROs top offerings with biology skills.
      S. Harachand , Contributing Editor 10.10.18

    • Packaging Majors Expand Base in India

      Packaging Majors Expand Base in India

      India’s pharma packaging market is growing at a faster pace than other world markets
      S. Harachand, Contributing Editor 03.09.18


    • Acquisition Spree

      Acquisition Spree

      Indian firms topped the list of aggressive bidders even as the frenzy of deal making in the global generics space passes into
      S. Harachand, Contributing Editor 01.30.18

    • Drug Delivery
      Growing NDDS Portfolios

      Growing NDDS Portfolios

      Generic drugs on novel delivery platforms
      S. Harachand, Contributing Editor 10.11.17

    • Supply Chain
      Marketing Code Round The Corner

      Marketing Code Round The Corner

      Proposal to limit giveaways; offenders face product ban
      S. Harachand, Contributing Editor 09.01.17

    Trending
    • Catalent Acquires Delphi Genetics
    • Inside A Vaccine Trial
    • Pfizer Selects Seven Bridges To Support RNA Sequencing Data
    • Pfizer Partners With Medicines Manufacturing Innovation Center
    • ICON Acquires Medpass
    Breaking News
    • Spark Therapeutics Appoints CTO
    • Cryoport Launches ESG Program
    • U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    • Thermo Fisher Scientific Completes Mesa Biotech Acquisition
    • Ashfield Engage, Popit Form Digital Monitoring Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login